Literature DB >> 17181397

Delayed development of Paget's disease in offspring inheriting SQSTM1 mutations.

Mark J Bolland1, Pak Cheung Tong, Dorit Naot, Karen E Callon, Diana J Wattie, Greg D Gamble, Tim Cundy.   

Abstract

UNLABELLED: Familial Paget's disease is associated with mutations in SQSTM1. We compared the age at diagnosis and severity of Paget's disease in parents with SQSTM1 mutations to their offspring who inherited a mutation. At any given age, the offspring were less likely to be diagnosed with Paget's disease and had less severe disease than their parents.
INTRODUCTION: Mutations in sequestosome 1 (SQSTM1) occur in 25-50% of cases of familial Paget's disease and are thought to be disease-causing. We sought to determine whether there are differences in age at diagnosis and severity of disease in parents and their offspring who share the same genetic predisposition to Paget's disease.
MATERIALS AND METHODS: Eighty-four offspring from 10 families (29 index patients with Paget's disease) with mutations in SQSTM1 were approached, and 58 agreed to participate. The ubiquitin-binding domain region of SQSTM1 was sequenced, and the presence or absence of the known mutation was established. The presence of Paget's disease in offspring who had inherited an SQSTM1 mutation was determined by bone scintigraphy and measurement of serum alkaline phosphatase (ALP).
RESULTS: Twenty-three of 58 offspring had inherited a germline mutation in SQSTM1. The mean ALP was 77 U/liter in offspring with mutations and 72 U/liter in those without mutations (p=0.84). Scintiscans from four offspring (mean age, 45 years; mean ALP, 139 U/liter; mean skeletal involvement, 6%) showed evidence of Paget's disease but were normal in the other 19 (mean age, 44 years; mean ALP, 64 U/liter). In comparison, in the 15 parents of the 23 offspring, the mean age of diagnosis was 48 years, the mean ALP was 850 U/liter, and the mean skeletal involvement was 30%. There was a 63% reduction in the risk of being diagnosed with Paget's disease at a comparable age in the offspring compared with the parents (p=0.028).
CONCLUSIONS: Only 17% of offspring inheriting an SQSTM1 mutation had evidence of Paget's disease on scintigraphy, and this was diagnosed at a later age and was less extensive than in their affected parents. SQSTM1 thus shows incomplete penetrance. The data are consistent with the hypothesis that an environmental factor is important in the pathogenesis and clinical phenotype of familial Paget's disease and that exposure to this factor may be falling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17181397     DOI: 10.1359/jbmr.061204

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  13 in total

1.  Paget's disease: epidemiology and pathophysiology.

Authors:  Margaret Seton
Journal:  Curr Osteoporos Rep       Date:  2008-12       Impact factor: 5.096

2.  SQSTM1 splice site mutation in distal myopathy with rimmed vacuoles.

Authors:  Robert C Bucelli; Khalid Arhzaouy; Alan Pestronk; Sara K Pittman; Luisa Rojas; Carolyn M Sue; Anni Evilä; Peter Hackman; Bjarne Udd; Matthew B Harms; Conrad C Weihl
Journal:  Neurology       Date:  2015-07-24       Impact factor: 9.910

Review 3.  Paget's disease of bone-genetic and environmental factors.

Authors:  Frederick R Singer
Journal:  Nat Rev Endocrinol       Date:  2015-08-18       Impact factor: 43.330

4.  Polymorphisms in autophagy genes are associated with paget disease of bone.

Authors:  Ricardo Usategui-Martín; Judith García-Aparicio; Luis Corral-Gudino; Ismael Calero-Paniagua; Javier Del Pino-Montes; Rogelio González Sarmiento
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

Review 5.  Pathobiology of Paget's Disease of Bone.

Authors:  Deborah L Galson; G David Roodman
Journal:  J Bone Metab       Date:  2014-05-31

Review 6.  Clinical and Genetic Advances in Paget's Disease of Bone: a Review.

Authors:  N Alonso; I Calero-Paniagua; J Del Pino-Montes
Journal:  Clin Rev Bone Miner Metab       Date:  2016-12-19

7.  Zoledronic acid prevents pagetic-like lesions and accelerated bone loss in the p62P394L mouse model of Paget's disease.

Authors:  Anna Daroszewska; Lorraine Rose; Nadine Sarsam; Gemma Charlesworth; Amanda Prior; Kenneth Rose; Stuart H Ralston; Robert J van 't Hof
Journal:  Dis Model Mech       Date:  2018-08-23       Impact factor: 5.758

Review 8.  Genetics of Paget's disease of bone.

Authors:  Stuart H Ralston; Omar M E Albagha
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

9.  Detection of SQSTM1/P392L post-zygotic mutations in Paget's disease of bone.

Authors:  Sabrina Guay-Bélanger; Sylvain Picard; Edith Gagnon; Jean Morissette; Ethel S Siris; Philippe Orcel; Jacques P Brown; Laëtitia Michou
Journal:  Hum Genet       Date:  2014-09-21       Impact factor: 4.132

10.  Paget disease of bone-associated UBA domain mutations of SQSTM1 exert distinct effects on protein structure and function.

Authors:  Alice Goode; Jed E Long; Barry Shaw; Stuart H Ralston; Micaela Rios Visconti; Fernando Gianfrancesco; Teresa Esposito; Luigi Gennari; Daniela Merlotti; Domenico Rendina; Sarah L Rea; Melanie Sultana; Mark S Searle; Robert Layfield
Journal:  Biochim Biophys Acta       Date:  2014-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.